To assess baseline predictors and consequences of antipsychotic adherence during long-
term treatment of schizophrenia outpatients, data were taken from the 3-year, prospective …

Objectives: This study aimed to prospectively identify the best single predictor and the best
set of predictors of risk for nonadherence with antipsychotic medication in the treatment of …

Objective: Approximately 40% of patients with schizophrenia are poorly adherent to their
antipsychotics at any given time. However, little is known about patients' adherence over …

Objective: To review the consequences of nonadherence to antipsychotic pharmacotherapy
in patients with schizophrenia, as well as associated risk factors for nonadherence and …

ObjectiveNonadherence to antipsychotic medication is highly prevalent in patients with
schizophrenia and has a deleterious impact on the course of the illness. This review seeks …

Nonadherence with medication occurs in all chronic medical disorders. It is a particular
challenge in schizophrenia due to the illness's association with social isolation, stigma, and …

Background: Nonadherence to medication is a recognized problem and may be the most
challenging aspect of treatment. Methods: We performed a systematic review of factors that …

Background: Relatively little is known about the relationships between medication
adherence and long-term functional outcomes in the treatment of schizophrenia. To extend …

Partial adherence and nonadherence to medication continue to be problems in the
treatment of patients with schizophrenia. Nonadherence to medication has a negative …

Objective: Although many clinicians acknowledge the occurrence of adherence problems
with medication regimens among patients with schizophrenia, the problem shows no sign of …